Yunnan Jianfeng Organization Non-coal Open-pit Mine Safety Special Training
Release time:
2020-08-14
Yunnan Jianfeng organized special training on safety of non-coal open-pit mines
News from our newspaper Recently, the Safety and Environmental Protection Department of Yunnan Jianfeng Cement Company held a special training meeting on safety of non-coal open-pit mines. The main person in charge of
mining company, the person in charge of blasting team and blasting workers participated in the training. At the meeting, the planning and preparation of the construction of the dual prevention mechanism of limestone mines, safety risk assessment, safety risk control, hidden danger investigation and management and assessment, improvement and promotion, etc., were shared and exchanged with mining companies.
The relevant person in charge of Yunnan Peak put forward requirements for comprehensively promoting the construction of dual prevention mechanisms in the non-coal mine field from four aspects: clear job responsibilities, safety risk identification, management and control, safety risk classification management and control, and hidden danger investigation and management: mines should set up a leading group for the construction of dual prevention mechanisms, combine with the original safety production management system, improve and form the dual prevention work system of the enterprise, and clarify the work content, the division of responsibilities and safeguard measures provide institutional guarantee for the normal operation of the dual prevention mechanism; the open-pit limestone mine shall conduct a comprehensive assessment and identification of the mine site according to the risk assessment technical methods such as Risk Management and Risk Assessment Technology (GB/T27921-2011 ), and delimit the major risk, relatively large risk, general risk and low risk areas of the mine according to the assessment results, for the identified safety risks, a safety risk notification column shall be set up in the corresponding places, and the spatial distribution map of safety risks of the whole mine shall be drawn on the mine drawings in red, orange, yellow and blue colors. According to the safety risk classification results, the mining company shall clarify the scope and responsibilities of each grade of safety risk corresponding to the person in charge, full-time and part-time safety production management personnel, team and post personnel, decompose the responsibility to everyone in the team in all links related to the production process, and strengthen the frequency of hidden danger investigation for places with major risks and greater risks; Combined with the construction of dual prevention mechanism, further improve the relevant system of enterprise hidden danger investigation and management, form the hidden danger investigation and management mechanism at the company level, mine level and team level, and do a good job of self-examination on the production site and basic management, in particular, it is necessary to strengthen the investigation of hidden dangers in basic management.
Lu Hongzheng, deputy general manager in charge of Yunnan Jianfeng, combined with the relevant accident cases of non-coal mine enterprises in recent years, analyzed the causes and responsibilities of the accident in a simple and profound way, and explained in detail the knowledge of safety management, inspection and supervision regulations, safety production standardization construction, mine safety production standardization, etc.
Through the training, the trainees have further understood the knowledge of safety production and occupational disease protection, improved the awareness of safety precautions and the consciousness of compliance with regulations and disciplines, and laid a good foundation for the continuous safe production of enterprises. (Liu Fengbin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31